A Cohort Study of Conversion From Aranesp to NESP for the Treatment of Anemia in Dialysis Patients
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- 03 Dec 2015 Planned End Date changed from 1 Dec 2016 to 1 May 2017 as reported by ClinicalTrials.gov.
- 03 Dec 2015 Planned primary completion date changed from 1 Jun 2016 to 1 Nov 2016 as reported by ClinicalTrials.gov.
- 03 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.